Apellis Pharmaceuticals, Inc.·4

Apr 21, 4:23 PM ET

WHEELER CRAIG A 4

4 · Apellis Pharmaceuticals, Inc. · Filed Apr 21, 2025

Insider Transaction Report

Form 4
Period: 2025-04-17
Transactions
  • Award

    Stock Option (Right to Buy)

    2025-04-17$18.20/sh+28,195$513,14928,195 total
    Exercise: $18.20Exp: 2032-04-17Common Stock (28,195 underlying)
  • Award

    Common Stock

    2025-04-17+16,48316,483 total
Footnotes (2)
  • [F1]This restricted stock unit was granted on April 17, 2025. The restricted stock unit will fully vest on the first anniversary of the date of grant, subject to his continued service as a director, or upon later termination of his service as adirector at his election.
  • [F2]This represents a stock option award granted April 17, 2025 that vest 1/3rd per year over a three-year period subject to continued service.

Documents

1 file
  • 4
    form4.xmlPrimary

    PRIMARY DOCUMENT